176 related articles for article (PubMed ID: 2985694)
21. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
Drobyski WR; Majewski D; Hanson G
Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
[TBL] [Abstract][Full Text] [Related]
22. Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.
Davenport C; George T; Devora GA; Morris MA; Gordon BE; Kumar V; Bennett M
Biol Blood Marrow Transplant; 1997 Dec; 3(6):294-303. PubMed ID: 9502296
[TBL] [Abstract][Full Text] [Related]
23. The nature of hemopoietic histocompatibility determinants. Differential sensitivity of Hh-1b and H-2b determinants to tunicamycin.
Milisauskas VK; Nakamura I
J Immunol; 1988 Aug; 141(4):1246-51. PubMed ID: 2456347
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of metastatic potential by gamma-interferon.
Kelly SA; Gschmeissner S; East N; Balkwill FR
Cancer Res; 1991 Aug; 51(15):4020-7. PubMed ID: 1906780
[TBL] [Abstract][Full Text] [Related]
25. Loss of marrow allograft resistance in mice with transplanted methylcholanthrene-induced sarcomas.
Kumar V; Bennett M
J Natl Cancer Inst; 1975 Aug; 55(2):489-92. PubMed ID: 240033
[TBL] [Abstract][Full Text] [Related]
26. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
[TBL] [Abstract][Full Text] [Related]
27. Leucyl-leucine methyl ester treatment of donor cells permits establishment of immunocompetent parent----F1 chimeras that are selectively tolerant of host alloantigens.
Thiele DL; Calomeni JA; Lipsky PE
J Immunol; 1987 Oct; 139(7):2137-42. PubMed ID: 3309052
[TBL] [Abstract][Full Text] [Related]
28. Abrogation of hybrid resistance to bone marrow engraftment by graft-vs-host-induced immune deficiency.
Hakim FT; Shearer GM
J Immunol; 1986 Nov; 137(10):3109-16. PubMed ID: 3095424
[TBL] [Abstract][Full Text] [Related]
29. Bone marrow cell transplants involving intra-H-2 recombinant inbred mouse strains. Evidence that hemopoietic histocompatibility-1 (Hh-1) genes are distinct from H-2D or H-2L.
Rembecki RM; Kumar V; David CS; Bennett M
J Immunol; 1988 Oct; 141(7):2253-60. PubMed ID: 3049802
[TBL] [Abstract][Full Text] [Related]
30. [Graft versus host reaction and hybrid resistance in experimental models and clinical practice].
Clerici M; Villa ML; Clerici E
Boll Ist Sieroter Milan; 1988; 67(3):177-96. PubMed ID: 3072013
[TBL] [Abstract][Full Text] [Related]
31. Host CD4+ T lymphocytes are required for the synergistic action of interferon-alpha/beta and adoptively transferred immune cells in the inhibition of visceral ESb metastases.
Kaido TJ; Maury C; Gresser I
Cancer Res; 1995 Dec; 55(24):6133-9. PubMed ID: 8521404
[TBL] [Abstract][Full Text] [Related]
32. Class I-deficient hemopoietic cells and nonhemopoietic cells dominantly induce unresponsiveness of natural killer cells to class I-deficient bone marrow cell grafts.
Wu MF; Raulet DH
J Immunol; 1997 Feb; 158(4):1628-33. PubMed ID: 9029098
[TBL] [Abstract][Full Text] [Related]
33. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma.
Jones MS; Riley R; Hamilton BL; Paupe J; Perez D; Levy RB
Bone Marrow Transplant; 1994 Nov; 14(5):725-35. PubMed ID: 7889005
[TBL] [Abstract][Full Text] [Related]
34. Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent strain spleen cells. I. Induction of a nylon-adherent, Thy-1+Lyt-1+2- suppressor cell.
Kosmatopoulos K; Orbach-Arbouys S
J Immunol; 1987 Feb; 138(3):704-12. PubMed ID: 2879865
[TBL] [Abstract][Full Text] [Related]
35. Influence of alloreactive T cells on initial hematopoietic reconstitution after marrow transplantation.
Martin PJ
Exp Hematol; 1995 Feb; 23(2):174-9. PubMed ID: 7828674
[TBL] [Abstract][Full Text] [Related]
36. Natural antibodies to interferon-alpha and interferon-beta are a common feature of inbred mouse strains.
De Maeyer-Guignard J; De Maeyer E
J Immunol; 1986 Mar; 136(5):1708-11. PubMed ID: 3950401
[TBL] [Abstract][Full Text] [Related]
37. Natural resistance of lethally irradiated F1 hybrid mice to parental marrow grafts is a function of H-2/Hh-restricted effectors.
Daley JP; Nakamura I
J Exp Med; 1984 Apr; 159(4):1132-48. PubMed ID: 6368735
[TBL] [Abstract][Full Text] [Related]
38. Extensive proliferation of subsequently injected marrow cells in parental-to-F1 hematopoietic chimeras that restored normal stem cell concentration after initial transplantation.
Sonoda T; Hayashi C; Seike H; Nakayama H; Terasaka K; Morioka T; Nakano T; Kitamura Y
Exp Hematol; 1985 Feb; 13(2):143-50. PubMed ID: 2857651
[TBL] [Abstract][Full Text] [Related]
39. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
[TBL] [Abstract][Full Text] [Related]
40. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M
Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
